TJX Reports Strong Q4 & FY26 Results, Boosts Dividend by 13%, and Authorizes New $3.0B Share Buyback

summarizeSummary

TJX Companies reported Q4 and full year FY26 results well above plan, announced a 13% dividend increase, and authorized a new $3.0 billion share repurchase program, alongside providing positive FY27 guidance.

check_boxKey Events

• Strong Q4 & Full Year FY26 Performance

  The company reported Q4 consolidated comparable sales up 5% and adjusted diluted EPS of $1.43 (up 16%), both well above plan. Full year FY26 also saw consolidated comparable sales up 5% and adjusted diluted EPS of $4.73 (up 11%), exceeding plans.

• 13% Dividend Increase Announced

  TJX intends to increase its regular quarterly dividend by 13% to $0.48 per share, subject to board approval, demonstrating strong financial health and commitment to shareholder returns.

• New $3.0 Billion Share Repurchase Program

  The Board of Directors approved a new stock repurchase program authorizing up to an additional $3.0 billion of common stock, representing approximately 1.8% of outstanding shares. The company also plans to repurchase $2.50 to $2.75 billion of stock in FY27.

• Positive FY27 Outlook Provided

  For Q1 FY27, TJX expects consolidated comparable sales to be up 2% to 3% and diluted EPS in the range of $0.97 to $0.99. Full year FY27 guidance projects comparable sales up 2% to 3% and diluted EPS between $4.93 and $5.02.

auto_awesomeAnalysis

TJX Companies delivered a robust financial performance for both the fourth quarter and full fiscal year 2026, significantly exceeding its own plans across key metrics like comparable sales, pretax profit margin, and diluted earnings per share. This strong operational execution is further underscored by the company's commitment to shareholder returns, highlighted by a substantial 13% increase in its quarterly dividend and the authorization of a new $3.0 billion share repurchase program. The positive outlook for fiscal year 2027, with planned comparable sales growth and solid EPS guidance, suggests continued momentum. Investors should view this filing as a strong signal of the company's health and management's confidence, especially given the stock is trading near its 52-week high.